Furthermore, CRY1 and CRY2 isoforms have been differentially associated with cancer and may function as pro- or anti-tumorigenic factors depending on the type of cancer (Chan and Lamia, 2020; Chan et al., 2021; Shafi et al., 2021). This evidence concerns the gene CRY1 and cancer.